Healthcare News
Monthly obesity shot shows big weight loss in trial
A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed about 20% of their body weight over a year, researchers reported Monday in The New England Journal of Medicine.
Study finds patients with interrupted GLP-1 access still achieve significant weight loss
Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss
Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide
Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss
Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight or obesity compared to use of tirzepatide treatment alone.
Intermittent energy restriction may improve outcomes in people with obesity and type 2 diabetes
Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes